Vaccine and Infectious Disease Division
The annual Conference on Retroviruses and Opportunistic Infections (CROI) is taking place in Seattle, Washington the week of February 23-26, 2015. Established in 1993, CROI brings together over 4,000 participants from around the globe to inform, discuss and brainstorm about current and future directions to prevent the morbidity and mortality from HIV. Read more >
More Featured News from VIDD >
Off target effects of rectal tenofovir gel
The antiviral tenofovir is a widely used drug for HIV prevention and treatment as an oral pill. The Microbicides Trial Network (MTN) phase 1 clinical trial was designed to detect possible subtle yet important ‘off target’ effects from rectal 1% tenofovir gel formulation treatment.
More VIDD News >
VIDD highlights promotions, new hires, honors/awards and goings of its faculty and staff.